• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工胰腺的膳食检测算法:一项针对 1 型糖尿病青少年的随机对照临床试验。

A Meal Detection Algorithm for the Artificial Pancreas: A Randomized Controlled Clinical Trial in Adolescents With Type 1 Diabetes.

机构信息

Department of Biomedical Engineering, McGill University, Montreal, Quebec, Canada.

Department of Electrical and Computer Engineering, McGill University, Montreal, Quebec, Canada.

出版信息

Diabetes Care. 2021 Feb;44(2):604-606. doi: 10.2337/dc20-1232. Epub 2020 Dec 4.

DOI:10.2337/dc20-1232
PMID:33277302
Abstract

OBJECTIVE

We developed a meal detection algorithm for the artificial pancreas (AP+MDA) that detects unannounced meals and delivers automatic insulin boluses.

RESEARCH DESIGN AND METHODS

We conducted a randomized crossover trial in 11 adolescents aged 12-18 years with HbA ≥7.5% who missed one or more boluses in the past 6 months. We compared ) continuous subcutaneous insulin infusion (CSII), ) artificial pancreas (AP), and ) AP+MDA. Participants underwent three 9-h interventions involving breakfast with a bolus and lunch without a bolus.

RESULTS

In AP+MDA, the meal detection time was 40.0 (interquartile range 40.0-57.5) min. Compared with CSII, AP+MDA decreased the 4-h postlunch incremental area under the curve (iAUC) from 24.1 ± 9.5 to 15.4 ± 8.0 h ⋅ mmol/L ( = 0.03). iAUC did not differ between AP+MDA and AP (19.6 ± 10.4 h ⋅ mmol/L, = 0.21) or between AP and CSII ( = 0.33). The AP+MDA reduced time >10 mmol/L (58.0 ± 26.6%) compared with CSII (79.6 ± 27.5%, = 0.02) and AP (74.2 ± 20.6%, = 0.047).

CONCLUSIONS

The AP+MDA improved glucose control after an unannounced meal.

摘要

目的

我们开发了一种用于人工胰腺(AP+MDA)的进餐检测算法,该算法可检测未通知的进餐并自动给予胰岛素推注。

研究设计和方法

我们在 11 名年龄在 12-18 岁、HbA1c≥7.5%、过去 6 个月漏注 1 次或多次胰岛素的青少年中进行了一项随机交叉试验。我们比较了)持续皮下胰岛素输注(CSII)、)人工胰腺(AP)和)AP+MDA。参与者接受了 3 项 9 小时的干预,涉及带推注的早餐和不带推注的午餐。

结果

在 AP+MDA 中,进餐检测时间为 40.0(四分位间距 40.0-57.5)分钟。与 CSII 相比,AP+MDA 使午餐后 4 小时的增量曲线下面积(iAUC)从 24.1±9.5 降至 15.4±8.0 h ⋅ mmol/L( = 0.03)。AP+MDA 与 AP(19.6±10.4 h ⋅ mmol/L, = 0.21)或 AP 与 CSII( = 0.33)之间的 iAUC 无差异。AP+MDA 使时间>10 mmol/L 的时间减少(58.0±26.6%),与 CSII(79.6±27.5%, = 0.02)和 AP(74.2±20.6%, = 0.047)相比。

结论

AP+MDA 改善了未通知进餐后的血糖控制。

相似文献

1
A Meal Detection Algorithm for the Artificial Pancreas: A Randomized Controlled Clinical Trial in Adolescents With Type 1 Diabetes.人工胰腺的膳食检测算法:一项针对 1 型糖尿病青少年的随机对照临床试验。
Diabetes Care. 2021 Feb;44(2):604-606. doi: 10.2337/dc20-1232. Epub 2020 Dec 4.
2
Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.1型糖尿病青少年闭环治疗期间减少餐时大剂量胰岛素注射的安全性、有效性及葡萄糖代谢:一项随机临床试验
Diabetes Obes Metab. 2015 Dec;17(12):1173-9. doi: 10.1111/dom.12549. Epub 2015 Oct 9.
3
Automatic Detection and Estimation of Unannounced Meals for Multivariable Artificial Pancreas System.多变量人工胰腺系统中未宣布的进餐自动检测和估计。
Diabetes Technol Ther. 2018 Mar;20(3):235-246. doi: 10.1089/dia.2017.0364. Epub 2018 Feb 6.
4
Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus.青少年使用人工胰腺处理遗漏的零食大剂量胰岛素注射和估计不足的餐时大剂量胰岛素注射情况。
Pediatr Diabetes. 2016 Feb;17(1):28-35. doi: 10.1111/pedi.12230. Epub 2014 Oct 27.
5
Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.人工胰腺个性化模型预测控制(MPC)和比例积分微分(PID)控制算法的随机交叉比较
Diabetes Care. 2016 Jul;39(7):1135-42. doi: 10.2337/dc15-2344. Epub 2016 Jun 11.
6
A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.一种新型的胰岛素-普兰林肽双重激素人工胰腺用于 1 型糖尿病:一项随机对照交叉试验。
Diabetes Care. 2020 Mar;43(3):597-606. doi: 10.2337/dc19-1922. Epub 2020 Jan 23.
7
Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.闭环多模型概率预测控制器人工胰腺在监督下的宾馆环境中对青少年和成年人的性能。
Diabetes Technol Ther. 2018 May;20(5):335-343. doi: 10.1089/dia.2017.0424. Epub 2018 Apr 16.
8
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.双激素人工胰腺、单激素人工胰腺与常规胰岛素泵治疗对 1 型糖尿病患者血糖控制的比较:一项开放标签随机对照交叉试验。
Lancet Diabetes Endocrinol. 2015 Jan;3(1):17-26. doi: 10.1016/S2213-8587(14)70226-8. Epub 2014 Nov 27.
9
Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.1型糖尿病的多中心闭环/混合餐时大剂量胰岛素输注
Diabetes Technol Ther. 2014 Oct;16(10):623-32. doi: 10.1089/dia.2014.0050. Epub 2014 Sep 4.
10
Glucose outcomes of a learning-type artificial pancreas with an unannounced meal in type 1 diabetes.1 型糖尿病中未预告餐时学习型人工胰腺的血糖结局。
Comput Methods Programs Biomed. 2020 Jul;191:105416. doi: 10.1016/j.cmpb.2020.105416. Epub 2020 Feb 26.

引用本文的文献

1
The 'Designer' Artificial Pancreas: How Does Current Technology Mimic Pancreatic Physiology?“定制”人工胰腺:当前技术如何模拟胰腺生理功能?
Cureus. 2025 Jun 25;17(6):e86770. doi: 10.7759/cureus.86770. eCollection 2025 Jun.
2
Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based Cohort Study.错过和延迟进餐大剂量胰岛素对接受自动胰岛素输注治疗的 1 型糖尿病儿童和青少年血糖结果的影响:一项基于人群的两中心队列研究。
Diabetes Technol Ther. 2024 Dec;26(12):897-907. doi: 10.1089/dia.2024.0022. Epub 2024 Jun 24.
3
Continuous glucose monitoring for automatic real-time assessment of eating events and nutrition: a scoping review.
用于饮食事件和营养自动实时评估的连续血糖监测:一项范围综述
Front Nutr. 2024 Jan 8;10:1308348. doi: 10.3389/fnut.2023.1308348. eCollection 2023.
4
Data-driven meal events detection using blood glucose response patterns.基于血糖反应模式的数据驱动的进餐事件检测。
BMC Med Inform Decis Mak. 2023 Dec 8;23(1):282. doi: 10.1186/s12911-023-02380-4.
5
Evidence from clinical trials on high-risk medical devices in children: a scoping review.临床研究证据在儿童高风险医疗器械中的应用:范围综述。
Pediatr Res. 2024 Feb;95(3):615-624. doi: 10.1038/s41390-023-02819-4. Epub 2023 Sep 28.
6
Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?智能胰岛素与 1 型糖尿病的人工智能:真正的胜者会站起来吗?
Int J Mol Sci. 2023 Aug 24;24(17):13139. doi: 10.3390/ijms241713139.
7
Insulin Delivery Hardware: Pumps and Pens.胰岛素给药器械:泵和笔
Diabetes Technol Ther. 2023 Feb;25(S1):S30-S43. doi: 10.1089/dia.2023.2503.
8
Intelligent Control with Artificial Neural Networks for Automated Insulin Delivery Systems.用于自动胰岛素输送系统的基于人工神经网络的智能控制
Bioengineering (Basel). 2022 Nov 8;9(11):664. doi: 10.3390/bioengineering9110664.
9
Strategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy.战略性玩火:SGLT 抑制剂作为闭环胰岛素治疗的可能辅助手段。
J Diabetes Sci Technol. 2021 Nov;15(6):1232-1242. doi: 10.1177/19322968211035411. Epub 2021 Sep 24.